ELV
Elevance Health Inc
NYSE · Health Care
$338.98
+6.73 (+2.03%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 197.03B | 181.86B | 31.61B | 28.12B | 29.18B |
| Net Income | 5.60B | 4.65B | 4.10B | 3.74B | 3.83B |
| EPS | — | — | — | — | — |
| Profit Margin | 2.8% | 2.7% | 13.0% | 13.3% | 13.1% |
| Rev Growth | +8.3% | +8.3% | +3.4% | +22.0% | +4.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 15.90B | 15.90B | 24.12B | 22.79B | 22.49B |
| Total Equity | 21.77B | 21.77B | 46.97B | 48.97B | 48.10B |
| D/E Ratio | 0.73 | 0.73 | 0.51 | 0.47 | 0.47 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 8.65B | 7.58B | 7.65B | 6.88B | 7.45B |
| Free Cash Flow | — | — | 2.88B | 2.63B | 4.06B |